Plasminogen Activator Levels in Plasma and Urine during Exercise and Oral Contraceptive Use

Anne M Hedlin; Susan Milojevic; Andrew Korey

doi:10.1055/s-0038-1646751

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1978; 39(03): 743-750
DOI: 10.1055/s-0038-1646751

Original Article

Schattauer GmbH Stuttgart

Plasminogen Activator Levels in Plasma and Urine during Exercise and Oral Contraceptive Use

Anne M Hedlin

The Department of Physiology, University of Toronto and G. D. Searle and Co. of Canada Ltd., Toronto, Canada

,

Susan Milojevic

The Department of Physiology, University of Toronto and G. D. Searle and Co. of Canada Ltd., Toronto, Canada

,

Andrew Korey

The Department of Physiology, University of Toronto and G. D. Searle and Co. of Canada Ltd., Toronto, Canada

› Author Affiliations

Abstract

PDF Download

Summary

The effect of Demulen (ethinyl estradiol 0.05 mg and ethynodiol diacetate 1 mg) and exercise on the level of plasminogen activators was studied in 25 women (12 controls and 13 contraceptive users).Plasma plasminogen activator level was increased by the use of the oral contraceptive and further increased by exercise. Urine plasminogen activator level was unchanged by the use of Demulen but, in both groups of subjects, was decreased by exercise.

PDF (776 kb)

References

References
1 Abiko N, Von Kaulla K. 1971; Dissimilarity of human vascular plasminogen activator and human urokinase. Journal of Laboratory and Clinical Medicine 78: 354
2 Amris CJ, Starup J. 1967; The coagulation mechanism in oral contraception. Acta obstetricia et gynecologica Scandinavica 46: 78
3 Asbeck F, Lechler E, Van De Loo J. 1971; Das Verhalten des fibrinolytischen Systems unter Oestrogen-Gestagen-Kombination. Thrombosis et Diathesis Haemorrhagica Suppl. 48-50: 133
4 Asbeck F, Bolte A, Henning HD, Hordemann K, Latz R, Lechler E, Van De Loo J. 1972; The mechanism of intravascular activation of the fibrinolytic system during oral contraception. Haemostasis 1: 108
5 Astedt B. 1971; Low fibrinolytic activity of the veins during treatment with ethinyloestradiol. Acta obstetricia et gynecologica Scandinavica 50: 279
6 Bick RL, Thompson WB. 1972; Fibrinolytic activity. Obstetrics and Gynecology 39: 213
7 Biggs R, Macfarlane RG, Pilling J. 1947; Observations on fibrinolysis. Lancet 1: 402
8 Brakman P, Sobrero AJ, Astrup T. 1970; Effects of different systemic contraceptives on blood fibrinolysis. American Journal of Obstetrics and Gynecology 106: 187
9 Cohen RJ, Epstein SE, Cohen LS, Dennis LH. 1968; Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic receptor stimulation. Lancet 2: 1264
10 Davis GL, Abilgaard CF, Bernauer EM, Britton M. 1976; Fibrinolytic and hemostatic changes during and after maximal exercise in males. Journal of Applied Physiology 40: 287
11 Ferguson EW, Guest MM. 1974; Exercise, physical conditioning, blood coagulation and fibrinolysis. Thrombosis et Diathesis Haemorrhagica 31: 63
12 Hedlin AnneM. 1975; The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis. Thrombosis et Diathesis Haemorrhagica 33: 370
13 Hedlin AM, Monkhouse FC. 1971; Changes in spontaneous fibrinolytic activity during use of oral contraceptives. Obstetrics and Gynecology 37: 225
14 Hedner U, Nilsson IM, Isacson S. 1975; Effect of ethyloestrenol on fibrinolysis in the vessel wall. Thrombosis et Diathesis Haemorrhagica 34: 609
15 Iatridis SG, Ferguson JH. 1963; Effects of physical exercise on blood coagulation and fibrinolyisis. Journal of Applied Physiology 18: 337
16 Kuchinski CS, Fletcher AP, Sherry S. 1968; Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. Journal of Clinical Investigation 47: 1238
17 Menon IS, Madras MB, Burke F, Dewar HA. 1967; Effect of strenuous and graded exercise on fibrinolytic activity. Lancet 1: 700
18 Nilsson IM, Kullander S. 1967; Coagulation and fibrinolytic studies during use of gestagens. Acta obstetricia et gynecologica Scandinavica 46: 286
19 Painter RH, Charles AF. 1962; Characterization of a soluble plasminogen activator from kidney culture cells. American Journal of Physiology 202: 1125
20 Rosing DR, Brakman P, Redwood DR, Goldstein RE, Beiser GD, Astrup T. 1970; Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise. Circulation Research 27: 171
21 Sartwell PE. 1971; Oral contraceptives and thromboembolism: A further report. American Journal of Epidemiology 94: 192
22 Sawyer WD, Fletcher AP, Alkjaersig N, Sherry S. 1960; Studies on the thrombolytic activity of human plasma. Journal of Clinical Investigation 39: 426
23 Sherry S, Lindemyer RI, Fletcher AP, Alkjaersig N. 1959; Studies on enhanced fibrinolytic activity in man. Journal of Clinical Investigation 38: 810
24 Vessey MP, Doll R. 1968; Investigation of relationship between the use of oral contraceptives and thromboembolic disease. British Medical Journal 2: 199
25 Von Kaulla K. 1954; Urine adsorbate with fibrinolytic and thromboplastic properties. Journal of Laboratory and Clinical Medicine 44: 944
26 Vreeken J, Boomaard J, Deggeller K. 1966; Urokinase excretion in patients with renal disease. Acta medica Scandinavica 180: 153